Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

Identifying, monitoring and reducing preventable major bleeds in the hospital setting.

Caraballo D, Spyropoulos AC, Mahan CE.

J Thromb Thrombolysis. 2013 Jul;36(1):7-13. doi: 10.1007/s11239-012-0819-2.

PMID:
23054465
2.

Risk of falls and major bleeds in patients on oral anticoagulation therapy.

Donzé J, Clair C, Hug B, Rodondi N, Waeber G, Cornuz J, Aujesky D.

Am J Med. 2012 Aug;125(8):773-8. doi: 10.1016/j.amjmed.2012.01.033.

PMID:
22840664
3.

Major bleeding complications in a specialized anticoagulation service.

Fanikos J, Grasso-Correnti N, Shah R, Kucher N, Goldhaber SZ.

Am J Cardiol. 2005 Aug 15;96(4):595-8.

PMID:
16098319
4.

Optimizing Anticoagulation Management Through the Use of a Hospital Engagement Network Metric for Inpatient Anticoagulant-Associated Hemorrhage.

Hoffman JL, Aneese NJ, Schmidt KJ, Chaben AC, Smythe MA.

Ann Pharmacother. 2015 Dec;49(12):1305-10. doi: 10.1177/1060028015606470. Epub 2015 Sep 18.

PMID:
26386409
5.

Warfarin-related bleeding following open heart surgery in Nairobi.

Ogendo SW.

East Afr Med J. 2001 Mar;78(3):139-43.

PMID:
12002054
6.

Bleeding complications of oral anticoagulant treatment: an inception-cohort, prospective collaborative study (ISCOAT). Italian Study on Complications of Oral Anticoagulant Therapy.

Palareti G, Leali N, Coccheri S, Poggi M, Manotti C, D'Angelo A, Pengo V, Erba N, Moia M, Ciavarella N, Devoto G, Berrettini M, Musolesi S.

Lancet. 1996 Aug 17;348(9025):423-8.

PMID:
8709780
7.

Safety and low molecular weight heparin in older people in a hospital with ambulatory care.

Chan DK, Ong B, Almafragy H, Karr M, Hung AW, Liu JG.

Arch Gerontol Geriatr. 2006 Sep-Oct;43(2):233-41. Epub 2005 Dec 15.

PMID:
16359739
8.
9.

[Major closed-space bleeding in patients on anticoagulation with acenocoumarol (TAO) or non-fractionned heparin(HS): a case-control study].

Martínez Lacasa J, Juan N, Juliá J, Rodríguez-Carballeira M, de Diego I, Soto R, Garau J.

An Med Interna. 2008 Jan;25(1):9-14. Spanish.

PMID:
18377188
10.

Major bleeding risk in anticoagulated patients receiving concomitant antiplatelet therapy: a prospective study.

Donzé J, Rodondi N, Waeber G, Cornuz J, Aujesky D.

Thromb Res. 2013 Jun;131(6):502-7. doi: 10.1016/j.thromres.2013.04.033. Epub 2013 May 30.

PMID:
23726965
11.

Bleeding risk of patients with acute venous thromboembolism taking nonsteroidal anti-inflammatory drugs or aspirin.

Davidson BL, Verheijen S, Lensing AW, Gebel M, Brighton TA, Lyons RM, Rehm J, Prins MH.

JAMA Intern Med. 2014 Jun;174(6):947-53. doi: 10.1001/jamainternmed.2014.946.

PMID:
24733305
12.

Physical activity and risk of bleeding in elderly patients taking anticoagulants.

Frey PM, Méan M, Limacher A, Jaeger K, Beer HJ, Frauchiger B, Aschwanden M, Rodondi N, Righini M, Egloff M, Osterwalder J, Kucher N, Angelillo-Scherrer A, Husmann M, Banyai M, Matter CM, Aujesky D.

J Thromb Haemost. 2015 Feb;13(2):197-205. doi: 10.1111/jth.12793. Epub 2014 Dec 30.

13.

Minor bleeds alert for subsequent major bleeding in patients using vitamin K antagonists.

Veeger NJ, Piersma-Wichers M, Meijer K, Hillege HL.

Br J Haematol. 2011 May;153(4):508-14. doi: 10.1111/j.1365-2141.2011.08656.x. Epub 2011 Mar 21.

PMID:
21418182
14.

The risks of thromboembolism vs. recurrent gastrointestinal bleeding after interruption of systemic anticoagulation in hospitalized inpatients with gastrointestinal bleeding: a prospective study.

Sengupta N, Feuerstein JD, Patwardhan VR, Tapper EB, Ketwaroo GA, Thaker AM, Leffler DA.

Am J Gastroenterol. 2015 Feb;110(2):328-35. doi: 10.1038/ajg.2014.398. Epub 2014 Dec 16. Erratum in: Am J Gastroenterol. 2015 Mar;110(3):480.

PMID:
25512338
15.

Adverse outcomes of anticoagulant use among hospitalized patients with chronic kidney disease: a comparison of the rates of major bleeding events between unfractionated heparin and enoxaparin.

Saheb Sharif-Askari F, Syed Sulaiman SA, Saheb Sharif-Askari N, Al Sayed Hussain A, Railey MJ.

PLoS One. 2014 Sep 2;9(9):e106517. doi: 10.1371/journal.pone.0106517. eCollection 2014.

16.

Bleeding risk in very old patients on vitamin K antagonist treatment: results of a prospective collaborative study on elderly patients followed by Italian Centres for Anticoagulation.

Poli D, Antonucci E, Testa S, Tosetto A, Ageno W, Palareti G; Italian Federation of Anticoagulation Clinics.

Circulation. 2011 Aug 16;124(7):824-9. doi: 10.1161/CIRCULATIONAHA.110.007864. Epub 2011 Aug 1.

17.
18.

Dabigatran etexilate as second-line therapy in patients with a left ventricular assist device.

Terrovitis JV, Ntalianis A, Kapelios CJ, Vakrou S, Diakos N, Katsaros L, Tsamatsoulis M, Kaldara E, Charitos C, Nanas JN.

Hellenic J Cardiol. 2015 Jan-Feb;56(1):20-5.

19.

The clinical impact of bleeding during oral anticoagulant therapy: assessment of morbidity, mortality and post-bleed anticoagulant management.

Guerrouij M, Uppal CS, Alklabi A, Douketis JD.

J Thromb Thrombolysis. 2011 May;31(4):419-23. doi: 10.1007/s11239-010-0536-7.

PMID:
21181236
20.

Risks of oral anticoagulant therapy with increasing age.

Torn M, Bollen WL, van der Meer FJ, van der Wall EE, Rosendaal FR.

Arch Intern Med. 2005 Jul 11;165(13):1527-32.

PMID:
16009869

Supplemental Content

Support Center